| Literature DB >> 28109271 |
Maya Hürlimann1,2, Filippo-Franco Schiapparelli1,2, Niccolo Rotigliano1,2, Enrique Testa1, Felix Amsler3, Michael T Hirschmann4,5.
Abstract
BACKGROUND: Heterotopic ossification (HO) is a well-known complication after total hip arthroplasty (THA). Recently, the trend is to operate THA minimally invasive being less traumatic than standard approaches and promising a faster return to activity. The purpose of the study was to investigate if minimal invasive surgery (MIS), leads also to less HO after THA.Entities:
Keywords: Anterolateral minimal invasive approach; Direct anterior approach; Heterotopic ossification; Periarticular ossification; THA; Total hip arthroplasty; Transgluteal Bauer; Watson-Jones
Mesh:
Year: 2017 PMID: 28109271 PMCID: PMC5251274 DOI: 10.1186/s12891-017-1391-x
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Patient demographics as well as HO and complications divided by the type of THA approach used
| Approach | Total | |||||
|---|---|---|---|---|---|---|
| Standard | Minimally invasive | |||||
| STD | STD | AMIS | MIS-AL | |||
| Gender | ||||||
| Men | 21 | 16 | 22 | 10 | 69 | |
| Women | 21 | 12 | 17 | 15 | 65 | |
| Mean age | 42 | 28 | 39 | 25 | ||
| Comorbidities | ||||||
| Previous THA | 14 | 12 | 12 | 7 | 45 | |
| Diabetes mellitus | 5 | 5 | 7 | 5 | 22 | |
| Cardiovascular diseases | 24 | 15 | 22 | 15 | 76 | |
| Osteoporosis | 5 | 1 | 1 | 3 | 10 | |
| HO | ||||||
| Grade 0 | Count | 23 | 24 | 30 | 19 | 96 |
| % | 19,0% | 3,6% | 7,7% | 12,0% | ||
| Grade 1 | Count | 8 | 1 | 3 | 3 | 15 |
| % | 19,0% | 3,6% | 7,7% | 12,0% | ||
| Grade 2 | Count | 5 | 2 | 4 | 1 | 12 |
| % | 11,9% | 7,1% | 10,3% | 4,0% | ||
| Grade 3 | Count | 3 | 0 | 2 | 1 | 6 |
| % | 7,1% | 0,0% | 5,1% | 4,0% | ||
| Grade 4 | Count | 3 | 1 | 0 | 1 | 5 |
| % | 7,1% | 3,6% | 0,0% | 4,0% | ||
| Total | Count | 42 | 28 | 39 | 25 | 134 |
| % | 31,3% | 20,9% | 29,1% | 18,7% | ||
| Mean Stay in hospital | 42 | 28 | 39 | 25 | ||
| Intraoperative complications | 4 | 3 | 1 | 0 | 8 | |
| Early complications | ||||||
| Bleeding | 1 | 2 | 0 | 0 | 3 | |
| Wound healing problems/infection | 4 | 1 | 1 | 4 | 10 | |
| Cardiovascular events | 1 | 1 | 4 | 0 | 6 | |
| Pulmonary embolism | 0 | 0 | 1 | 0 | 1 | |
| Postoperative anemia | 42 | 28 | 39 | 25 | 134 | |
| Urinary tract infection | 5 | 1 | 0 | 0 | 6 | |
| Late complications | ||||||
| Fracture | 3 | 1 | 1 | 1 | 6 | |
| Dislocation | 0 | 2 | 1 | 0 | 3 | |
| Loosening | 1 | 0 | 0 | 0 | 1 | |
| Leg length discrepancy | 9 | 9 | 14 | 7 | 39 | |
| Trendelenburg sign/muscular deficits | 10 | 10 | 3 | 2 | 25 | |
| Local sensory disturbances/pain | 7 | 5 | 9 | 6 | 27 | |
| Revision surgery | 2 | 2 | 1 | 3 | 8 | |
Fig. 1One year follow-up standard radiographic control, examples of heterotopic ossification according to Brooker grade 1 (a), grade 2 (b), grade 3 (c) and grade 4 (d)
Pearson correlation of demographic and outcome criteria (* = 0.05 ** = 0.01 *** = 0.001)
| Pearson r |
| STD-Watson-Jones | STD-Bauer | AMIS | MIS-AL | MIS | Revision surgery | HO | Gender | Age | Previous THA |
| STD-Watson-Jones | 134 | 1*** | −0.35*** | −0.43*** | −0.32*** | −0.65*** | −0.03 | 0.22** | 0.02 | 0.03 | 0 |
| STD-Bauer | 134 | −0.35*** | 1*** | −0.33*** | −0.25** | −0.49*** | 0.03 | −0.12 | −0.06 | 0.01 | 0.1 |
| AMIS | 134 | −0.43*** | −0.33*** | 1*** | −0.31*** | 0.67*** | −0.09 | −0.08 | −0.06 | 0.07 | −0.04 |
| MIS-AL | 134 | −0.32*** | −0.25** | −0.31*** | 1*** | 0.5*** | 0.12 | −0.04 | 0.11 | −0.12 | −0.06 |
| MIS | 134 | −0.65*** | −0.49*** | 0.67*** | 0.5*** | 1*** | 0.01 | −0.11 | 0.03 | −0.03 | −0.08 |
| Revision surgery | 134 | −0.03 | 0.03 | −0.09 | 0.12 | 0.01 | 1*** | 0.04 | 0.13 | 0.11 | 0.02 |
| HO | 134 | 0.22** | −0.12 | −0.08 | −0.04 | −0.11 | 0.04 | 1*** | 0.11 | 0.14 | 0.16 |
| Gender | 134 | 0.02 | −0.06 | −0.06 | 0.11 | 0.03 | 0.13 | 0.11 | 1*** | 0.02 | 0.04 |
| Age | 134 | 0.03 | 0.01 | 0.07 | −0.12 | −0.03 | 0.11 | 0.14 | 0.02 | 1*** | −0.07 |
| Previous THA | 134 | 0 | 0.1 | −0.04 | −0.06 | −0.08 | 0.02 | 0.16 | 0.04 | −0.07 | 1*** |
| Diabetes | 134 | −0.08 | 0.02 | 0.03 | 0.05 | 0.06 | −0.03 | −0.05 | 0.09 | 0.09 | −0.02 |
| Cardiovascular diseases | 134 | 0.01 | −0.03 | 0 | 0.03 | 0.02 | 0.16 | 0.03 | −0.24** | 0.48*** | −0.18* |
| Osteoporosis | 134 | 0.11 | −0.08 | −0.12 | 0.08 | −0.04 | 0.05 | 0.22* | 0.24** | 0.05 | 0.1 |
| Hospital stay | 134 | 0.13 | 0.04 | −0.24** | 0.09 | −0.15 | 0.39*** | 0.17 | 0.2* | 0.22* | 0.12 |
| Intraoperative complications | 134 | 0.1 | 0.1 | −0.09 | −0.12 | −0.18* | 0.2* | 0.07 | 0.13 | 0.16 | 0.02 |
| Bleeding | 134 | 0.01 | 0.17* | −0.1 | −0.07 | −0.14 | −0.04 | −0.08 | 0.05 | 0.03 | 0 |
| Wound healing problems/ infections | 134 | 0.05 | −0.08 | −0.12 | 0.16 | 0.01 | 0.41*** | 0.03 | 0.07 | −0.06 | −0.02 |
| Cardiovascular events | 134 | −0.07 | −0.02 | 0.18* | −0.1 | 0.08 | 0.1 | −0.02 | 0.01 | 0.04 | −0.15 |
| Pulmonary embolism | 134 | −0.06 | −0.04 | 0.14 | −0.04 | 0.09 | −0.02 | −0.05 | −0.08 | 0.05 | 0.12 |
| Postoperative anemia | 134 | 0.15 | −0.05 | −0.04 | −0.07 | −0.1 | 0.21* | 0.06 | 0.17* | 0.1 | 0 |
| Urinary tract infections | 134 | 0.24** | −0.02 | −0.14 | −0.1 | −0.21* | 0.1 | 0.15 | 0.15 | 0.07 | 0 |
| Other neurological deficits/delirium | 134 | −0.01 | 0.13 | −0.12 | 0.01 | −0.1 | −0.07 | −0.07 | −0.05 | 0.18* | 0.04 |
| Fractures | 134 | 0.09 | −0.02 | −0.06 | −0.01 | −0.06 | 0.25** | 0.19* | 0.15 | 0.24** | 0.08 |
| Dislocation | 134 | −0.1 | 0.17* | 0.01 | −0.07 | −0.04 | 0.17* | 0.01 | 0.05 | 0.09 | −0.11 |
| Loosening | 134 | 0.13 | −0.04 | −0.06 | −0.04 | −0.08 | 0.34*** | 0.12 | −0.08 | 0 | −0.06 |
| Leg length discrepancy | 134 | −0.11 | 0.03 | 0.1 | −0.01 | 0.08 | −0.09 | −0.1 | 0 | −0.03 | −0.04 |
| Trendelenburg sign/muscular deficits | 134 | 0.09 | 0.23** | −0.18* | −0.13 | −0.27** | 0.04 | 0.07 | 0.07 | 0.06 | 0.07 |
| Local sensory disturbances/pain | 134 | −0.06 | −0.03 | 0.05 | 0.05 | 0.08 | 0.19* | 0.1 | 0.03 | −0.12 | 0 |
| Pearson r |
| Diabetes | Cardiovasc. diseases | Osteoporosis | Hospital stay | Intraoperative complications | Bleeding | Wound healing problems/infections | Cardiovascular events | Pulmonary embolism | Postoperative anemia |
| STD-Watson-Jones | 134 | −0.08 | 0.01 | 0.11 | 0.13 | 0.1 | 0.01 | 0.05 | −0.07 | −0.06 | 0.15 |
| STD-Bauer | 134 | 0.02 | −0.03 | −0.08 | 0.04 | 0.1 | 0.17* | −0.08 | −0.02 | −0.04 | −0.05 |
| AMIS | 134 | 0.03 | 0 | −0.12 | −0.24** | −0.09 | −0.1 | −0.12 | 0.18* | 0.14 | −0.04 |
| MIS-AL | 134 | 0.05 | 0.03 | 0.08 | 0.09 | −0.12 | −0.07 | 0.16 | −0.1 | −0.04 | −0.07 |
| MIS | 134 | 0.06 | 0.02 | −0.04 | −0.15 | −0.18* | −0.14 | 0.01 | 0.08 | 0.09 | −0.1 |
| Revision surgery | 134 | −0.03 | 0.16 | 0.05 | 0.39*** | 0.2* | −0.04 | 0.41*** | 0.1 | −0.02 | 0.21* |
| HO | 134 | −0.05 | 0.03 | 0.22* | 0.17 | 0.07 | −0.08 | 0.03 | −0.02 | −0.05 | 0.06 |
| Gender | 134 | 0.09 | −0.24** | 0.24** | 0.2* | 0.13 | 0.05 | 0.07 | 0.01 | −0.08 | 0.17* |
| Age | 134 | 0.09 | 0.48*** | 0.05 | 0.22* | 0.16 | 0.03 | −0.06 | 0.04 | 0.05 | 0.1 |
| Previous THA | 134 | −0.02 | −0.18* | 0.1 | 0.12 | 0.02 | 0 | −0.02 | −0.15 | 0.12 | 0 |
| Diabetes | 134 | 1*** | 0.27** | 0.03 | −0.03 | −0.03 | −0.07 | −0.05 | 0 | 0.2* | 0.16 |
| Cardiovasc. diseases | 134 | 0.27** | 1*** | −0.15 | 0.1 | 0.09 | 0.03 | 0.08 | −0.03 | 0.08 | 0.17* |
| Osteoporosis | 134 | 0.03 | −0.15 | 1*** | 0.12 | 0.05 | −0.04 | 0.03 | −0.06 | −0.02 | 0.02 |
| Hospital stay | 134 | −0.03 | 0.1 | 0.12 | 1*** | 0.19* | 0.15 | 0.29*** | −0.06 | −0.07 | 0.12 |
| Intraoperative complications | 134 | −0.03 | 0.09 | 0.05 | 0.19* | 1*** | 0.39*** | 0.17 | −0.05 | −0.02 | 0.29*** |
| Bleeding | 134 | −0.07 | 0.03 | −0.04 | 0.15 | 0.39*** | 1*** | −0.04 | −0.03 | −0.01 | 0.06 |
| Wound healing problems/ infections | 134 | −0.05 | 0.08 | 0.03 | 0.29*** | 0.17 | −0.04 | 1*** | −0.06 | −0.02 | 0.16 |
| Cardiovasc. events | 134 | 0 | −0.03 | −0.06 | −0.06 | −0.05 | −0.03 | −0.06 | 1*** | −0.02 | −0.1 |
| Pulmonary embolism | 134 | 0.2* | 0.08 | −0.02 | −0.07 | −0.02 | −0.01 | −0.02 | −0.02 | 1*** | 0.19* |
| Postoperative anemia | 134 | 0.16 | 0.17* | 0.02 | 0.12 | 0.29*** | 0.06 | 0.16 | −0.1 | 0.19* | 1*** |
| Urinary tract infections | 134 | 0.1 | 0.04 | 0.08 | 0.12 | 0.1 | −0.03 | 0.35*** | −0.05 | −0.02 | 0.18* |
| Other neurological deficits/delirium | 134 | −0.05 | 0.02 | 0.14 | 0.1 | 0.05 | 0.15 | −0.08 | −0.06 | −0.02 | 0.09 |
| Fractures | 134 | 0.06 | 0.16 | 0.06 | 0.33*** | 0.58*** | 0.32*** | 0.52*** | 0.12 | 0.15 | 0.67*** |
| Dislocation | 134 | 0 | 0.12 | 0.08 | 0.21* | 0.55*** | −0.03 | 0.21* | −0.05 | −0.02 | 0.28** |
| Loosening | 134 | −0.07 | 0.13 | −0.04 | −0.04 | 0.17* | 0.32*** | 0.15 | −0.03 | −0.01 | 0.06 |
| Leg length discrepancy | 134 | −0.04 | 0.08 | −0.02 | −0.02 | −0.02 | −0.01 | −0.02 | −0.02 | −0.01 | 0.19* |
| Trendelenburg sign/muscular deficits | 134 | −0.02 | −0.07 | −0.12 | −0.15 | −0.02 | 0.01 | 0.07 | 0.18* | 0.14 | 0.04 |
| Local sensory disturbances/pain | 134 | −0.06 | −0.01 | 0.16 | 0.07 | 0.04 | 0.06 | 0.01 | −0.01 | −0.04 | 0.08 |
| Pearson r | N | Urinary tract infections | Other neurological Deficits/delirium | Fractures | Dislocation | Loosening | Leg length discrepancy | Trendelenburg sign/muscular deficits | Local sensory disturbances/pain | ||
| STD-Watson-Jones | 134 | 0.24** | −0.01 | 0.09 | −0.1 | 0.13 | −0.11 | 0.09 | −0.06 | ||
| STD-Bauer | 134 | −0.02 | 0.13 | −0.02 | 0.17* | −0.04 | 0.03 | 0.23** | −0.03 | ||
| AMIS | 134 | −0.14 | −0.12 | −0.06 | 0.01 | −0.06 | 0.1 | −0.18* | 0.05 | ||
| MIS-AL | 134 | −0.1 | 0.01 | −0.01 | −0.07 | −0.04 | −0.01 | −0.13 | 0.05 | ||
| MIS | 134 | −0.21* | −0.16 | −0.06 | −0.04 | −0.08 | 0.08 | −0.27** | 0.08 | ||
| Revision surgery | 134 | 0.1 | 0.36*** | 0.25** | 0.17* | 0.34*** | −0.09 | 0.04 | 0.19* | ||
| HO | 134 | 0.15 | 0.04 | 0.19* | 0.01 | 0.12 | −0.1 | 0.07 | 0.1 | ||
| Gender | 134 | 0.15 | 0.17* | 0.15 | 0.05 | −0.08 | 0 | 0.07 | 0.03 | ||
| Age | 134 | 0.07 | 0.16 | 0.24** | 0.09 | 0 | −0.03 | 0.06 | −0.12 | ||
| Previous THA | 134 | 0 | −0.01 | 0.08 | −0.11 | −0.06 | −0.04 | 0.07 | 0 | ||
| Diabetes | 134 | 0.1 | 0.06 | 0 | −0.07 | −0.04 | −0.02 | −0.06 | −0.02 | ||
| Cardiovasc. diseases | 134 | 0.04 | 0.16 | 0.12 | 0.13 | 0.08 | −0.07 | −0.01 | −0.05 | ||
| Osteoporosis | 134 | 0.08 | 0.06 | 0.08 | −0.04 | −0.02 | −0.12 | 0.16 | −0.07 | ||
| Hospital stay | 134 | 0.12 | 0.33*** | 0.21* | −0.04 | −0.02 | −0.15 | 0.07 | −0.09 | ||
| Intraoperative complications | 134 | 0.1 | 0.58*** | 0.55*** | 0.17* | −0.02 | −0.02 | 0.04 | 0.03 | ||
| Bleeding | 134 | −0.03 | 0.32*** | −0.03 | 0.32*** | −0.01 | 0.01 | 0.06 | −0.08 | ||
| Wound healing problems/infections | 134 | 0.35*** | 0.52*** | 0.21* | 0.15 | −0.02 | 0.07 | 0.01 | 0.14 | ||
| Cardiovascular events | 134 | −0.05 | 0.12 | −0.05 | −0.03 | −0.02 | 0.18* | −0.01 | 0.07 | ||
| Pulmonary embolism | 134 | −0.02 | 0.15 | −0.02 | −0.01 | −0.01 | 0.14 | −0.04 | −0.04 | ||
| Postoperative anemia | 134 | 0.18* | 0.67*** | 0.28** | 0.06 | 0.19* | 0.04 | 0.08 | 0.01 | ||
| Urinary tract infection | 134 | 1*** | 0.5*** | 0.3*** | −0.03 | −0.02 | 0.1 | 0.08 | 0.16 | ||
| Other neurological deficits/delirium | 134 | 0.21* | 0.39*** | −0.06 | −0.04 | −0.02 | −0.06 | 0.01 | −0.07 | ||
| Fractures | 134 | 0.5*** | 1*** | 0.37*** | 0.2* | 0.05 | 0.11 | 0.07 | 0.08 | ||
| Dislocation | 134 | 0.3*** | 0.37*** | 1*** | −0.03 | −0.02 | −0.06 | 0.17* | 0.07 | ||
| Loosening | 134 | −0.03 | 0.2* | −0.03 | 1*** | −0.01 | 0.13 | 0.06 | 0.18* | ||
| Leg length discrepancy | 134 | −0.02 | 0.05 | −0.02 | −0.01 | 1*** | −0.06 | −0.04 | 0.17* | ||
| Trendelenburg sign/muscular deficits | 134 | 0.1 | 0.11 | −0.06 | 0.13 | −0.06 | 1*** | 0.03 | 0.05 | ||
| Local sensory disturbances/pain | 134 | 0.08 | 0.07 | 0.17* | 0.06 | −0.04 | 0.03 | 1*** | −0.05 |